The NARAL' Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC:A Clinical Trial by the Danish Lung Cancer Group

Autor: Sloth Møller, Ditte, Andersen, Jon L, Appelt, Ane L, Brink, Carsten, Hansen, Olfred, Hoffmann, Lone, Jensen, Nikolaj K G, Josipovic, Mirjana, Khalil, Azza Ahmed, Marquard Knap, Marianne, Lund, Mikkel D, Lutz, Christina Maria, Nielsen, Martin Skovmos, Kunwald Nielsen, Svetlana, Nielsen, Tine B, Nyhus, Christina H, Ottoson, Wiviann, Persson, Gitte F, Sibolt, Patrik, Wedervang, Kim, Schytte, Tine

Publikováno v: Sloth Møller, D, Andersen, J L, Appelt, A L, Brink, C, Hansen, O, Hoffmann, L, Jensen, N K G, Josipovic, M, Khalil, A A, Marquard Knap, M, Lund, M D, Lutz, C M, Nielsen, M S, Kunwald Nielsen, S, Nielsen, T B, Nyhus, C H, Ottoson, W, Persson, G F, Sibolt, P, Wedervang, K & Schytte, T 2015, ' The NARAL" Phase III Trial: Heterogeneous FDG-GUided Dose Escalation of Advanced NSCLC : A Clinical Trial by the Danish Lung Cancer Group ', Journal of Thoracic Oncology, vol. 10, no. 9, Suppl. 2, pp. S286-5287 . https://doi.org/10.1016/S1556-0864(16)30011-9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3c8bae619a6196bff01469164ef1cb6b
https://vbn.aau.dk/da/publications/9e463359-9f8c-4c90-8ad9-512cfd968f2b